Royalty Pharma (RPRX) Change in Acquisitions & Divestments (2019 - 2025)
Historic Change in Acquisitions & Divestments for Royalty Pharma (RPRX) over the last 7 years, with Q4 2025 value amounting to $2.9 million.
- Royalty Pharma's Change in Acquisitions & Divestments fell 7711.74% to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $21.2 million, marking a year-over-year increase of 727.79%. This contributed to the annual value of $21.2 million for FY2025, which is 727.79% up from last year.
- Latest data reveals that Royalty Pharma reported Change in Acquisitions & Divestments of $2.9 million as of Q4 2025, which was down 7711.74% from $2.9 million recorded in Q3 2025.
- In the past 5 years, Royalty Pharma's Change in Acquisitions & Divestments registered a high of $624.4 million during Q3 2021, and its lowest value of $1.4 million during Q1 2024.
- Its 5-year average for Change in Acquisitions & Divestments is $144.4 million, with a median of $24.4 million in 2023.
- In the last 5 years, Royalty Pharma's Change in Acquisitions & Divestments crashed by 9409.62% in 2024 and then soared by 77402.78% in 2025.
- Over the past 5 years, Royalty Pharma's Change in Acquisitions & Divestments (Quarter) stood at $104.7 million in 2021, then increased by 10.43% to $115.6 million in 2022, then plummeted by 78.91% to $24.4 million in 2023, then crashed by 48.4% to $12.6 million in 2024, then tumbled by 77.12% to $2.9 million in 2025.
- Its Change in Acquisitions & Divestments was $2.9 million in Q4 2025, compared to $2.9 million in Q3 2025 and $2.9 million in Q2 2025.